Mr Daniel Hassan
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
I am a PhD student in the SAiGENCI T-cell Immunotherapy Laboratory, supervised by Dr. Mara Zeissig. My project involves investigating the role of precursor exhausted T cells (Tpex cells) in anti-tumour immunity. These cells are the major reservoir of anti-tumour T cells in a patient and expand greatly with immune checkpoint blockade therapy, such as those that target the PD-1/PD-L1 pathway. While such therapies have had great success, patient response to therapy is mixed. My work aims to identify new therapeutic targets on Tpex cells that may be incorporated into a combination therapy with immune checkpoint blockades to help improve results within those non-responding patients.
| Date | Position | Institution name |
|---|---|---|
| 2026 - ongoing | PhD Student | Adelaide University |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2026 | Scholarship | Playford Trust PhD Scholarship | The Playford Trust | Australia | - |
| 2026 | Award | University Medal | University of Adelaide | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2026 | South Australian immunoGENomics Cancer Institute | Australia | Doctor of Philosophy (PhD) |
| 2025 - 2025 | University of Adelaide | Australia | Honours in Molecular and Biomedical Science |
| 2022 - 2024 | University of Adelaide | Australia | Bachelor of Science (Advanced) |
| Year | Citation |
|---|---|
| 2026 | Wong, Y. Y., Harbison, J., Hassan, D., Gundsambuu, B., Hope, C., Wong, S. W., . . . Barry, S. (2026). Integrative epigenomic and transcriptomic profiling reveals dysregulated T cell regulatory networks in Stage 3 Type 1 diabetes. Research Square. Genome Medicine (Under Review). |
2026-2029 - South Australian Immunogenomics Cancer Institute (SAiGENCI) Scholarship; Research Training Program Scholarship
2026-2029 - South Australian Immunogenomics Cancer Institute (SAiGENCI) Top-Up Scholarship